Mo Li

4.1k total citations · 1 hit paper
131 papers, 2.7k citations indexed

About

Mo Li is a scholar working on Molecular Biology, Pharmaceutical Science and Oncology. According to data from OpenAlex, Mo Li has authored 131 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 26 papers in Pharmaceutical Science and 23 papers in Oncology. Recurrent topics in Mo Li's work include Drug Solubulity and Delivery Systems (21 papers), Advanced Drug Delivery Systems (17 papers) and Crystallization and Solubility Studies (12 papers). Mo Li is often cited by papers focused on Drug Solubulity and Delivery Systems (21 papers), Advanced Drug Delivery Systems (17 papers) and Crystallization and Solubility Studies (12 papers). Mo Li collaborates with scholars based in China, United States and Hong Kong. Mo Li's co-authors include Xiaochun Yu, Shengying Qin, Lu Shen, Lin He, Cong Huai, Na Zhang, Mingzhe Zhao, Qiang Fu, Xianglong Zhao and Bixuan Jiang and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Mo Li

121 papers receiving 2.6k citations

Hit Papers

Cytochrome P450 Enzymes and Drug Metabolism in Humans 2021 2026 2022 2024 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mo Li China 24 1.1k 432 423 402 306 131 2.7k
Weimin Cai China 26 681 0.6× 183 0.4× 352 0.8× 107 0.3× 332 1.1× 162 2.6k
Cosmo Rossi Italy 31 1.5k 1.4× 208 0.5× 741 1.8× 155 0.4× 101 0.3× 70 3.2k
Xinwen Wang China 38 1.7k 1.5× 175 0.4× 448 1.1× 243 0.6× 381 1.2× 154 4.6k
Jingyuan Wen New Zealand 37 1.4k 1.3× 1.0k 2.3× 292 0.7× 111 0.3× 219 0.7× 124 4.0k
Jie Fu China 26 1.1k 1.0× 309 0.7× 169 0.4× 81 0.2× 315 1.0× 133 2.8k
Kunihiko Itoh Japan 32 1.5k 1.4× 158 0.4× 472 1.1× 308 0.8× 262 0.9× 205 4.3k
Xin Huang China 31 1.2k 1.1× 172 0.4× 472 1.1× 94 0.2× 304 1.0× 194 3.1k
Chiung‐Tong Chen Taiwan 29 1.2k 1.1× 235 0.5× 430 1.0× 64 0.2× 174 0.6× 84 2.8k
Xiaoyu Xu China 32 1.6k 1.5× 126 0.3× 250 0.6× 85 0.2× 243 0.8× 224 4.1k

Countries citing papers authored by Mo Li

Since Specialization
Citations

This map shows the geographic impact of Mo Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mo Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mo Li more than expected).

Fields of papers citing papers by Mo Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mo Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mo Li. The network helps show where Mo Li may publish in the future.

Co-authorship network of co-authors of Mo Li

This figure shows the co-authorship network connecting the top 25 collaborators of Mo Li. A scholar is included among the top collaborators of Mo Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mo Li. Mo Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ailin, Qinhui Liu, Yimin Xiong, et al.. (2025). Tirzepatide reduces body weight by increasing fat utilization via the central nervous system‐adipose tissue axis in male mice. Diabetes Obesity and Metabolism. 27(5). 2844–2856. 3 indexed citations
2.
Zhan, Mei, Qi Long, Jinhan He, et al.. (2025). Immune checkpoint inhibitor-induced diabetes mellitus: clinical characteristics and risk factors. Frontiers in Immunology. 16. 1499074–1499074. 2 indexed citations
3.
Yu, Peng, Wanqing Jia, Jingming Li, et al.. (2025). Dual role of polyphenols in walnut protein extraction and functionality: Implications for processing and utilization. Food Hydrocolloids. 172. 112051–112051. 1 indexed citations
5.
Song, Dandan, Ruilong Ma, Mo Li, et al.. (2024). Self-crosslinking hyaluronic acid hydrogel as an enteroprotective agent for the treatment of inflammatory bowel disease. International Journal of Biological Macromolecules. 273(Pt 2). 132909–132909. 10 indexed citations
6.
7.
Yu, Peng, et al.. (2024). Comparative analysis of twin-screw pressing and blending methods for walnut oleosome extraction: Yield, physical stability, and functionalities. Journal of Food Engineering. 386. 112292–112292. 7 indexed citations
8.
Li, Jiarui, Ze Xiang, Ce Gao, et al.. (2023). Immunotherapy of hepatocellular carcinoma: recent progress and new strategy. Frontiers in Immunology. 14. 23 indexed citations
9.
He, Miao, Yajing Zhao, Yujia Liu, et al.. (2023). Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients. Thoracic Cancer. 14(33). 3282–3294. 4 indexed citations
10.
Li, Mo, et al.. (2023). The miR‐669a‐5p/G3BP/HDAC6/AKAP12 Axis Regulates Primary Cilia Length. Advanced Science. 11(6). e2305068–e2305068. 3 indexed citations
11.
Zhang, Yixuan, Mo Li, Ying Zhang, et al.. (2023). MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling. Biomarker Research. 11(1). 1–1. 33 indexed citations
12.
Li, Mo, Qiwei Li, Jieying Pu, et al.. (2023). The small RNA PrrH of Pseudomonas aeruginosa regulates hemolysis and oxidative resistance in bloodstream infection. Microbial Pathogenesis. 180. 106124–106124. 5 indexed citations
13.
Li, Mo, et al.. (2023). Comparison of in vivo behaviors of intramuscularly long-acting celecoxib nanosuspensions with different particle sizes for the postoperative pain treatment. International Journal of Pharmaceutics. 636. 122793–122793. 15 indexed citations
14.
Wang, Zijun, Mo Li, Xiaofan Sui, et al.. (2022). Programmed pH-responsive core–shell nanoparticles for precisely targeted therapy of ulcerative colitis. Nanoscale. 15(4). 1937–1946. 28 indexed citations
15.
Liu, Wei, Mo Li, Geyu Zhou, et al.. (2020). Leveraging functional annotation to identify genes associated with complex diseases. PLoS Computational Biology. 16(11). e1008315–e1008315. 13 indexed citations
16.
Ma, Yarui, Siyuan He, Aiai Gao, et al.. (2020). Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma. Clinical Epigenetics. 12(1). 25–25. 16 indexed citations
17.
Li, Mo, et al.. (2016). Analytical and numerical solutions to the amplifier with incoherent pulse temporal overlap. Optics Communications. 382. 49–57. 4 indexed citations
18.
Lyu, Jihui, Xiang Li, Wenjie Li, et al.. (2015). The effectiveness evaluation of multiple discipline intervention for delirium diagnosis and treatment in elderly inpatients. Zhonghua laonian yixue zazhi. 34(12). 1306–1309.
19.
Li, Mo, et al.. (2014). High prevalence of obstructive sleep apnea in Marfan's syndrome. Chinese Medical Journal. 127(17). 3150–3155. 11 indexed citations
20.
Lyu, Jihui, et al.. (2014). The effect of music therapy on memory, language and psychological symptoms of patients with mild Alzheimer’s disease. Chin J Neurol. 47(12). 831–835. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026